Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

[Outcomes of treatment of 32 cases of advanced or relapsed post-surgery pulmonary sarcomatoid carcinoma].

Xiong WJ, Zhang XX, Huang MJ, Chen L, Song LL, Xue JX, Wang YS, Lu Y.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2014 Mar;45(2):320-3. Chinese.

PMID:
24749366
2.
3.
4.
5.
6.

Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma.

Rodriguez J, Cortes J, Calvo E, Azinovic I, Fernandez-Hildago O, Martinez-Monge R, Garzon C, de Irala J, Martinez-Aguillo M, Ramon Y Cajal T, Brugarolas A.

Cancer. 2000 Dec 15;89(12):2622-9.

PMID:
11135224
7.

A retrospective study: platinum-based induction chemotherapy combined with gemcitabine or paclitaxel for stage IIB-IIIA central non-small-cell lung cancer.

Lv C, Ma Y, Wu N, Yan S, Zheng Q, Sun Y, Li S, Fang J, Yang Y.

World J Surg Oncol. 2013 Mar 21;11:76. doi: 10.1186/1477-7819-11-76.

8.

[Efficacy and toxicity of pemetrexed or gemcitabine combined with cisplatin in the treatment of patients with advanced non-small cell lung cancer].

Hu X, Jiao S, Zhang S, Wang Z, Wang M, Huang C, Zheng R, Li K, Wang J, Wang Y, Ouyang X, Lv W, Cheng G, Hu C, Luo R, Sun Y.

Zhongguo Fei Ai Za Zhi. 2012 Oct;15(10):569-75. doi: 10.3779/j.issn.1009-3419.2012.10.02. Chinese.

9.

Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens.

Kosmas C, Tsavaris N, Vadiaka M, Stavroyianni N, Koutras A, Malamos N, Onyenadum A, Rokana S, Polyzos A, Kalofonos HP.

Cancer. 2001 Dec 1;92(11):2902-10.

PMID:
11753965
10.

[Treatment and prognosis of 117 patients with advanced urothelial carcinoma of the bladder].

Song Y, Yang L, Zhou A, Chi Y, Wang J.

Zhonghua Zhong Liu Za Zhi. 2014 Mar;36(3):212-6. Chinese.

PMID:
24785283
12.

[A randomized comparative trial of three combined regimens containing cisplatin for treatment of advanced non-small cell lung cancer].

Liu L, Wang XW, Li L, Zhang X, Zhang WD, Yu XJ.

Ai Zheng. 2006 Aug;25(8):990-4. Chinese.

PMID:
16965680
14.

Induction chemotherapy and chemoradiation therapy for inoperable locally advanced non-small-cell lung cancer: a single-institution review of two different regimens.

Kocak M, Ozkan A, Mayadagli A, Parlak C, Bilici A, Seker M, Oven Ustaalioglu BB, Gumus M, Eren M, Karabulut SG, Oruc F.

Clin Lung Cancer. 2009 Mar;10(2):124-9. doi: 10.3816/CLC.2009.n.016.

PMID:
19362956
15.

Long-term survival after treatment with gemcitabine and oxaliplatin with and without paclitaxel plus secondary surgery in patients with cisplatin-refractory and/or multiply relapsed germ cell tumors.

Oechsle K, Kollmannsberger C, Honecker F, Mayer F, Waller CF, Hartmann JT, Boehlke I, Bokemeyer C; German Testicular Cancer Study Group..

Eur Urol. 2011 Oct;60(4):850-5. doi: 10.1016/j.eururo.2011.06.019.

PMID:
21704446
16.

Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04).

Iranzo V, Sirera R, Carrato A, Cabrera A, Jantus E, Guijarro R, Sanmartín E, Blasco A, Gil M, Gómez-Aldaraví L, González-Larriba JL, Massuti B, Velasco A, Provencio M, Rossell R, Camps C.

Clin Transl Oncol. 2011 Jun;13(6):411-8.

PMID:
21680302
17.

Phase II study of gemcitabine-cisplatin-paclitaxel triplet as induction chemotherapy in inoperable, locally-advanced non-small cell lung cancer.

Cappuzzo F, De Marinis F, Nelli F, Calandri C, Maestri A, Benedetti G, Migliorino MR, Cortesi E, Rastelli F, Martelli O, Andruccetti M, Bartolini S, Crinò L.

Lung Cancer. 2003 Dec;42(3):355-61.

PMID:
14644524
18.

A phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401.

Oh IJ, Kim KS, Kim YC, Ban HJ, Kwon YS, Kim YI, Lim SC, Chung WK, Nam TK, Song JY, Yoon MS, Ahn SJ.

Cancer Chemother Pharmacol. 2013 Dec;72(6):1247-54. doi: 10.1007/s00280-013-2308-5.

PMID:
24091849
19.

Paclitaxel-based chemotherapy in carcinoma of the fallopian tube.

Gemignani ML, Hensley ML, Cohen R, Venkatraman E, Saigo PE, Barakat RR.

Gynecol Oncol. 2001 Jan;80(1):16-20.

PMID:
11136563
20.

Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients.

Holloway RW, Mehta RS, Finkler NJ, Li KT, McLaren CE, Parker RJ, Fruehauf JP.

Gynecol Oncol. 2002 Oct;87(1):8-16.

PMID:
12468336
Items per page

Supplemental Content

Support Center